Allient (ALNT) Competitors $21.65 +1.76 (+8.85%) Closing price 04/9/2025 04:00 PM EasternExtended Trading$21.64 -0.01 (-0.05%) As of 04/9/2025 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALNT vs. TXG, TRNS, CTKB, SENS, LAB, EYPT, QTRX, QSI, AEHR, and MASSShould you be buying Allient stock or one of its competitors? The main competitors of Allient include 10x Genomics (TXG), Transcat (TRNS), Cytek Biosciences (CTKB), Senseonics (SENS), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Quanterix (QTRX), Quantum-Si (QSI), Aehr Test Systems (AEHR), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Allient vs. 10x Genomics Transcat Cytek Biosciences Senseonics Standard BioTools EyePoint Pharmaceuticals Quanterix Quantum-Si Aehr Test Systems 908 Devices 10x Genomics (NASDAQ:TXG) and Allient (NASDAQ:ALNT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, community ranking, earnings, dividends, analyst recommendations, valuation and profitability. Which has preferable valuation & earnings, TXG or ALNT? Allient has lower revenue, but higher earnings than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$610.79M1.74-$182.63M-$1.52-5.70Allient$529.97M0.69$24.10M$0.8027.06 Do insiders and institutionals have more ownership in TXG or ALNT? 84.7% of 10x Genomics shares are held by institutional investors. Comparatively, 61.6% of Allient shares are held by institutional investors. 10.0% of 10x Genomics shares are held by company insiders. Comparatively, 15.6% of Allient shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community believe in TXG or ALNT? 10x Genomics received 55 more outperform votes than Allient when rated by MarketBeat users. However, 75.00% of users gave Allient an outperform vote while only 50.83% of users gave 10x Genomics an outperform vote. CompanyUnderperformOutperform10x GenomicsOutperform Votes6150.83% Underperform Votes5949.17% AllientOutperform Votes675.00% Underperform Votes225.00% Is TXG or ALNT more profitable? Allient has a net margin of 2.64% compared to 10x Genomics' net margin of -29.90%. Allient's return on equity of 10.80% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-29.90% -25.40% -19.69% Allient 2.64%10.80%4.75% Do analysts prefer TXG or ALNT? 10x Genomics currently has a consensus target price of $20.21, suggesting a potential upside of 133.15%. Allient has a consensus target price of $31.00, suggesting a potential upside of 43.19%. Given 10x Genomics' higher probable upside, research analysts clearly believe 10x Genomics is more favorable than Allient.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 1 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.35Allient 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Which has more volatility & risk, TXG or ALNT? 10x Genomics has a beta of 2.01, suggesting that its stock price is 101% more volatile than the S&P 500. Comparatively, Allient has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500. Does the media favor TXG or ALNT? In the previous week, 10x Genomics had 4 more articles in the media than Allient. MarketBeat recorded 10 mentions for 10x Genomics and 6 mentions for Allient. Allient's average media sentiment score of 1.13 beat 10x Genomics' score of 0.81 indicating that Allient is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 10x Genomics 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Allient 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAllient beats 10x Genomics on 11 of the 19 factors compared between the two stocks. Remove Ads Get Allient News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALNT vs. The Competition Export to ExcelMetricAllientInstruments to measure electricity IndustryComputer SectorNASDAQ ExchangeMarket Cap$366.92M$3.67B$22.40B$7.60BDividend Yield0.59%0.57%2.92%4.27%P/E Ratio24.6019.6039.3618.06Price / Sales0.692.332,219.4690.67Price / Cash6.8617.8734.6334.64Price / Book1.393.035.773.95Net Income$24.10M$135.28M$735.35M$247.18M7 Day Performance5.97%4.54%-0.36%0.06%1 Month Performance-3.69%-3.61%49,625.69%-5.03%1 Year Performance-31.73%-15.77%52,738.26%-3.63% Allient Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALNTAllient4.4571 of 5 stars$21.65+8.8%$31.00+43.2%-33.5%$366.92M$529.97M24.601,950Positive NewsTXG10x Genomics4.6236 of 5 stars$8.73-4.7%$20.21+131.5%-76.8%$1.07B$610.79M-5.741,240Analyst ForecastNews CoverageGap DownTRNSTranscat2.4967 of 5 stars$74.45+1.5%$111.50+49.8%-31.7%$693.06M$272.20M40.24920News CoveragePositive NewsCTKBCytek Biosciences1.6121 of 5 stars$4.01+0.3%$6.42+60.0%-45.9%$513.67M$200.45M-50.12500Gap DownSENSSenseonics1.0479 of 5 stars$0.66-2.9%$2.00+204.8%+15.3%$427.68M$22.47M-5.0590Gap DownLABStandard BioTools2.6965 of 5 stars$1.08-5.3%$2.88+166.2%-60.3%$409.31M$174.43M-1.52620Positive NewsGap DownEYPTEyePoint Pharmaceuticals1.7296 of 5 stars$5.42-7.0%$26.63+391.2%-78.8%$372.51M$43.27M-2.71120Positive NewsGap DownQTRXQuanterix2.6929 of 5 stars$6.51-0.8%$18.25+180.3%-74.3%$252.43M$135.44M-6.14460Positive NewsGap DownQSIQuantum-Si2.7226 of 5 stars$1.20-5.5%$3.48+189.6%-34.9%$219.77M$3.06M-1.88150Gap DownAEHRAehr Test Systems3.3621 of 5 stars$7.29-7.5%$25.00+242.9%-25.6%$216.60M$50.74M9.7290Earnings ReportNews CoverageGap UpMASS908 Devices2.9174 of 5 stars$4.48+10.9%$5.33+19.0%-42.6%$158.28M$59.63M-2.5360Analyst ForecastNews CoverageGap Down Remove Ads Related Companies and Tools Related Companies 10x Genomics Alternatives Transcat Alternatives Cytek Biosciences Alternatives Senseonics Alternatives Standard BioTools Alternatives EyePoint Pharmaceuticals Alternatives Quanterix Alternatives Quantum-Si Alternatives Aehr Test Systems Alternatives 908 Devices Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALNT) was last updated on 4/10/2025 by MarketBeat.com Staff From Our PartnersThe Most Bullish Metric For Stocks (NOT Volume…)Before placing a single trade, Tim Sykes always checks one key bullish metric. It’s the same signal that has s...MillPub | SponsoredTrump’s policies mean HUGE income for investorsThanks to a Trump win… Investors have a HUGE opportunity at new income. The floodgates for U.S. oil prod...The Oxford Club | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy crypto may be the best way to play this chaotic market …Wall Street is in chaos … Over $6 trillion was wiped … in just two days. But something else was happenin...Weiss Ratings | SponsoredBITCOINYou're not going to believe this. There's a bizarre new way to make money from crypto... ...and it's not...Awesomely, LLC | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allient Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allient With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALNT Stock Free ALNT Stock Alerts